Metraipolis › archive › dc_fee5251f1085

Efficacy and Safety of Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma: A Product-Specific Systematic Review and Meta-Analysis of… — Europe PMC PMID:42496442

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42496442
DOI
10.3390/hematolrep18040043
License (as archived)
solo-consultazione
Archived
2026-10-19T06:21:52.437Z
SHA-256 of the archived text
f9f06fabe5effadfb33a193d37b0659577ed14a9dd34344f6d00420f2929abca
Stable URL of this page
https://metraipolis.com/documento/dc_fee5251f1085

How to cite

Efficacy and Safety of Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma: A Product-Specific Systematic Review and Meta-Analysis of… — Europe PMC PMID:42496442 — Europe PMC (en), https://europepmc.org/article/MED/42496442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fee5251f1085 (Metraipolis archive dc_fee5251f1085, sha256 f9f06fabe5effadfb33a193d37b0659577ed14a9dd34344f6d00420f2929abca)
BibTeX
@misc{dcfee5251f1085,
  title = {Efficacy and Safety of Lisocabtagene Maraleucel in Relapsed or Refractory Large B-Cell Lymphoma: A Product-Specific Systematic Review and Meta-Analysis of… — Europe PMC PMID:42496442},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42496442},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fee5251f1085; sha256 f9f06fabe5effadfb33a193d37b0659577ed14a9dd34344f6d00420f2929abca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42496442. Agents can read the archived copy with the MCP tool read_document.